Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹52 Cr₹48 Cr₹37 Cr₹6.13 Cr₹197 Cr

What is the latest Consolidated Net Profit of BALAXI PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of BALAXI PHARMACEUTICALS is ₹52 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹52 Cr
Mar2023₹48 Cr
Mar2022₹37 Cr
Mar2021₹6.13 Cr
Mar2020₹197 Cr

How is Consolidated Net Profit of BALAXI PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹52 Cr
7.39
Mar2023 ₹48 Cr
29.41
Mar2022 ₹37 Cr
507.51
Mar2021 ₹6.13 Cr
-96.88
Mar2020 ₹197 Cr -

Compare Consolidated Net Profit of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹322.2 Cr -6.7% -13.4% -45.9% Stock Analytics
ADANI ENTERPRISES ₹271,382.0 Cr 1% 4.4% -18.9% Stock Analytics
REDINGTON ₹19,192.6 Cr 9.7% 7.7% 8.8% Stock Analytics
MMTC ₹8,725.5 Cr 15.2% 15.1% -21.2% Stock Analytics
HONASA CONSUMER ₹7,537.8 Cr 1.8% 6.9% -38.9% Stock Analytics
LLOYDS ENTERPRISES ₹6,760.1 Cr 4.3% 28.4% 73.9% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-6.7%

-13.4%

-45.9%

SENSEX

0.8%

3.8%

8.4%


You may also like the below Video Courses